1-7 of 7
Suhendan Ekmekcioglu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma

Sun-Hee Kim, Jason Roszik, Sung-Nam Cho, Dai Ogata, Denái R. Milton, Weiyi Peng, David G. Menter, Suhendan Ekmekcioglu, Elizabeth A. Grimm
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (5): 1650–1663.
https://doi.org/10.1158/1078-0432.CCR-18-1163
Published: 01 March 2019
View article titled, The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma
Open the PDF for The COX2 Effector Microsomal PGE2 Synthase 1 is a Regulator of Immunosuppression in Cutaneous Melanoma in another window
Includes: Supplementary data
Journal Articles

Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma

Suhendan Ekmekcioglu, Michael A. Davies, Keiji Tanese, Jason Roszik, Myung Shin-Sim, Roland L. Bassett, Jr, Denái R. Milton, Scott E. Woodman, Victor G. Prieto, Jeffrey E. Gershenwald, Donald L. Morton, Dave S. Hoon, Elizabeth A. Grimm
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (12): 3016–3024.
https://doi.org/10.1158/1078-0432.CCR-15-2226
Published: 14 June 2016
View article titled, Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma
Open the PDF for Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma in another window
Includes: Supplementary data
Journal Articles

Molecular Pathways: Inflammation-Associated Nitric-Oxide Production as a Cancer-Supporting Redox Mechanism and a Potential Therapeutic Target

Elizabeth A. Grimm, Andrew G. Sikora, Suhendan Ekmekcioglu
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2013) 19 (20): 5557–5563.
https://doi.org/10.1158/1078-0432.CCR-12-1554
Published: 14 October 2013
View article titled, Molecular Pathways: Inflammation-Associated Nitric-Oxide Production as a Cancer-Supporting Redox Mechanism and a Potential Therapeutic Target
Open the PDF for Molecular Pathways: Inflammation-Associated Nitric-Oxide Production as a Cancer-Supporting Redox Mechanism and a Potential Therapeutic Target in another window
Journal Articles

Oncogenic BRAF(V600E) Promotes Stromal Cell-Mediated Immunosuppression Via Induction of Interleukin-1 in Melanoma

Jahan S. Khalili, Shujuan Liu, Tania G. Rodríguez-Cruz, Mayra Whittington, Seth Wardell, Chengwen Liu, Minying Zhang, Zachary A. Cooper, Dennie T. Frederick, Yufeng Li, Min Zhang, Richard W. Joseph, Chantale Bernatchez, Suhendan Ekmekcioglu, Elizabeth Grimm, Laszlo G. Radvanyi, Richard E. Davis, Michael A. Davies, Jennifer A. Wargo, Patrick Hwu, Gregory Lizée
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (19): 5329–5340.
https://doi.org/10.1158/1078-0432.CCR-12-1632
Published: 30 September 2012
View article titled, Oncogenic BRAF(V600E) Promotes Stromal Cell-Mediated Immunosuppression Via Induction of Interleukin-1 in Melanoma
Open the PDF for Oncogenic BRAF(V600E) Promotes Stromal Cell-Mediated Immunosuppression Via Induction of Interleukin-1 in Melanoma in another window
Includes: Supplementary data
Journal Articles

Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma

Julie A. Ellerhorst, Victoria R. Greene, Suhendan Ekmekcioglu, Carla L. Warneke, Marcella M. Johnson, Carolyn P. Cooke, Li-E Wang, Victor G. Prieto, Jeffrey E. Gershenwald, Qingyi Wei, Elizabeth A. Grimm
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (2): 229–235.
https://doi.org/10.1158/1078-0432.CCR-10-2276
Published: 16 January 2011
View article titled, Clinical Correlates of <em>NRAS</em> and <em>BRAF</em> Mutations in Primary Human Melanoma
Open the PDF for Clinical Correlates of <em>NRAS</em> and <em>BRAF</em> Mutations in Primary Human Melanoma in another window
Journal Articles

Targeted Inhibition of Inducible Nitric Oxide Synthase Inhibits Growth of Human Melanoma In vivo and Synergizes with Chemotherapy

Andrew G. Sikora, Alexander Gelbard, Michael A. Davies, Daisuke Sano, Suhendan Ekmekcioglu, John Kwon, Yared Hailemichael, Padmini Jayaraman, Jeffrey N. Myers, Elizabeth A. Grimm, Willem W. Overwijk
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (6): 1834–1844.
https://doi.org/10.1158/1078-0432.CCR-09-3123
Published: 14 March 2010
View article titled, Targeted Inhibition of Inducible Nitric Oxide Synthase Inhibits Growth of Human Melanoma <em>In vivo</em> and Synergizes with Chemotherapy
Open the PDF for Targeted Inhibition of Inducible Nitric Oxide Synthase Inhibits Growth of Human Melanoma <em>In vivo</em> and Synergizes with Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Inducible Nitric Oxide Synthase and Nitrotyrosine in Human Metastatic Melanoma Tumors Correlate with Poor Survival

Suhendan Ekmekcioglu, Julie Ellerhorst, Christine M. Smid, Victor G. Prieto, Mark Munsell, Antonio C. Buzaid, Elizabeth A. Grimm
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (12): 4768–4775.
Published: 01 December 2000
View article titled, Inducible Nitric Oxide Synthase and Nitrotyrosine in Human Metastatic Melanoma Tumors Correlate with Poor Survival
Open the PDF for Inducible Nitric Oxide Synthase and Nitrotyrosine in Human Metastatic Melanoma Tumors Correlate with Poor Survival in another window